VIDEO: What you should know about enterovirus-D68

Article

As Mary Anne Jackson, MD, Division Director, Infectious Disease, Department of Pediatrics and Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine, reports in our exclusive interview, as of October 14th, the CDC had begun utilizing a new, faster lab test for detecting the virus.

 

As Mary Anne Jackson, MD, Division Director, Infectious Disease, Department of Pediatrics and Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine, reports in our exclusive interview, as of October 14th, the CDC had begun utilizing a new, faster lab test for detecting the virus. She notes that no adult cases have yet been identified, suggesting that prior exposure to EV-D68 has conferred immunity to the current virus. That hypothesis may be apt in that the virus is not a new one, having first been identified in 1962 per CDC.

At press time, the CDC had convened a panel of experts that is expected to release interim management guidelines the first week of November.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
© 2025 MJH Life Sciences

All rights reserved.